Detalles de la búsqueda
1.
DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT).
J Asthma
; 57(10): 1110-1118, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293211
2.
Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study.
Pharmacoepidemiol Drug Saf
; 29(2): 219-223, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914920
3.
Cost-Effectiveness and Impact on Health Care Utilization of Interventions to Improve Medication Adherence and Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.
J Allergy Clin Immunol Pract
; 12(5): 1228-1243, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38182099
4.
Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD.
Eur Clin Respir J
; 8(1): 1833411, 2020 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33144930
5.
Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study).
NPJ Prim Care Respir Med
; 30(1): 1, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31911607
Resultados
1 -
5
de 5
1
Próxima >
>>